Shukra Pharmaceuticals has witnessed a dramatic surge in its stock price, rising by an impressive 90% in the past month. As of January 24, 2025, the stock closed at 224.60.

Performance Breakdown: Shukra Pharmaceuticals in the Last 30 Days

Over the past month, Shukra Pharmaceuticals has delivered steady gains, with a consistent upward trend day after day. Here’s a snapshot of the stock’s price performance (as per Investing) over the last 30 days:

Date Price Open High Low Volume Change %
Jan 24, 2025 224.60 224.60 224.60 224.60 21.24K +2.00%
Jan 23, 2025 220.20 216.00 220.20 216.00 241.96K +1.99%
Jan 22, 2025 215.90 215.90 215.90 215.90 16.04K +1.98%
Jan 21, 2025 211.70 211.70 211.70 211.70 16.05K +2.00%
Jan 20, 2025 207.55 207.55 207.55 207.55 62.33K +1.99%
Jan 17, 2025 203.50 203.50 203.50 203.50 153.99K +1.98%
Jan 16, 2025 199.55 199.55 199.55 199.55 12.78K +1.99%
Jan 15, 2025 195.65 195.65 195.65 195.65 16.65K +1.98%
Jan 14, 2025 191.85 191.85 191.85 191.85 14.95K +1.99%
Jan 13, 2025 188.10 188.10 188.10 188.10 29.64K +1.98%
Jan 10, 2025 184.45 177.25 184.45 177.25 204.31K +1.99%
Jan 09, 2025 180.85 180.85 180.85 180.85 71.86K +1.97%
Jan 08, 2025 177.35 177.35 177.35 177.35 94.28K +1.98%
Jan 07, 2025 173.90 173.90 173.90 173.90 148.26K +4.98%
Jan 06, 2025 165.65 165.65 165.65 158.55 137.74K +4.97%
Jan 03, 2025 157.80 157.80 157.80 157.80 44.96K +4.99%
Jan 02, 2025 150.30 150.30 150.30 150.25 58.28K +4.99%
Jan 01, 2025 143.15 143.15 143.15 142.05 116.68K +4.97%
Dec 31, 2024 136.37 135.00 136.37 135.00 36.63K +5.00%

As seen in the table, the stock has seen consistent growth, with gains averaging around 1.98% to 5.00% per day. The most notable jumps occurred on January 7 and January 6, where the stock rose by nearly 5% in a single day.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.